Cite
HARVARD Citation
Choi, J. et al. (2017). Assessment of Tocilizumab (Anti–Interleukin‐6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody‐Mediated Rejection and Transplant Glomerulopathy in HLA‐Sensitized Renal Allograft Recipients. American journal of transplantation. 17 (9), pp. 2381-2389. [Online].